VolitionRx (NYSEAMERICAN:VNRX) Shares Cross Above 50 Day Moving Average of $0.00

Shares of VolitionRx Limited (NYSEAMERICAN:VNRX) crossed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $0.00 and traded as high as $0.91. VolitionRx shares last traded at $0.88, with a volume of 78,163 shares trading hands.

VolitionRx Stock Up 1.4 %

The company has a market capitalization of $55.49 million, a P/E ratio of -1.57 and a beta of 1.59.

VolitionRx (NYSEAMERICAN:VNRX) last posted its quarterly earnings data on Monday, March 25th. The medical research company reported ($0.11) EPS for the quarter. VolitionRx had a negative return on equity of 15,493.47% and a negative net margin of 9,158.31%. The company had revenue of $0.24 million during the quarter, compared to analyst estimates of $0.50 million. On average, equities research analysts predict that VolitionRx Limited will post -0.5 EPS for the current fiscal year.

VolitionRx Company Profile

VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.